跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRAMESTON 2.5 TABLET 2.5 mg - HSA Drug Approval Details
Approvals
/
HSA
/
BRAMESTON 2.5 TABLET 2.5 mg
Approved
THERAPEUTIC
BRAMESTON 2.5 TABLET 2.5 mg
REMEDICA LTD (CYPRUS)
🇸🇬 Health Sciences Authority
Approval Date
May 20, 1997
Approval ID
5f62c317b266ea0e
Company
REMEDICA LTD (CYPRUS)
Type
Therapeutic
Approval Details
Approval Id
5f62c317b266ea0e
Drug Name
BRAMESTON 2.5 TABLET 2.5 mg
Product Name
BRAMESTON 2.5 TABLET 2.5 mg
Approval Number
SIN09507P
Approval Date
1997-05-20
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
G02CB01
Atc Item Name
bromocriptine
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Active Ingredients
BROMOCRIPTINE MESYLATE EQV BROMOCRIPTINE
2.5 mg
BROMOCRIPTINE MESYLATE EQV BROMOCRIPTINE
2.5 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 20, 1997
Approval ID
5f62c317b266ea0e
Type
Therapeutic
Back to HSA Approvals